An asparagine to threonine substitution in the 1A domain of keratin 1:: a novel mutation that causes epidermolytic hyperkeratosis

被引:13
作者
Arin, MJ
Longley, MA
Küster, W
Huber, M
Hohl, D
Rothnagel, JA
Roop, DR
机构
[1] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA
[3] TOMESA, Clin Allergy Skin & Joint Dis & Rheumatism, Bad Salzschlirf, Germany
[4] Hop Belmont, CHUV, Dept Dermatol, Lausanne, Switzerland
关键词
keratin; 1; intermediate filaments; genodermatosis; epidermolytic hyperkeratosis;
D O I
10.1111/j.1600-0625.1999.tb00359.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Epidermolytic hyperkeratosis (EHK) is a congenital, autosomal dominant disorder of cornification characterized by hyperkeratosis and blister formation. The clinical manifestations are heterogeneous, with respect to the extent of body surface involvement, palmar and plantar hyperkeratosis and the presence of erythroderma. Point mutations in the genes encoding the suprabasal-specific keratins, keratins 1 and 10 have been identified in EHK patients. The inappropriate amino acid substitutions cause a collapse of the keratin filament network, resulting in cytolysis of the involved keratinocytes. We report a severe case of EHK with a single base pair mutation that causes a threonine for asparagine substitution in residue 8 (N8T) of the 1A region of the keratin 1 protein. This is the region involved in molecular overlaps between neighboring keratin heterodimers. These findings suggest that even conservative amino acid substitutions in overlap regions can cause tonofilament clumping.
引用
收藏
页码:124 / 127
页数:4
相关论文
共 12 条
[1]   THE GENETIC-BASIS OF EPIDERMOLYTIC HYPERKERATOSIS - A DISORDER OF DIFFERENTIATION-SPECIFIC EPIDERMAL KERATIN GENES [J].
CHENG, J ;
SYDER, AJ ;
YU, QC ;
LETAI, A ;
PALLER, AS ;
FUCHS, E .
CELL, 1992, 70 (05) :811-819
[2]  
CHIPEV CC, 1994, AM J HUM GENET, V54, P179
[3]   A LEUCINE-]PROLINE MUTATION IN THE H1 SUBDOMAIN OF KERATIN-1 CAUSES EPIDERMOLYTIC HYPERKERATOSIS [J].
CHIPEV, CC ;
KORGE, BP ;
MARKOVA, N ;
BALE, SJ ;
DIGIOVANNA, JJ ;
COMPTON, JG ;
STEINERT, PM .
CELL, 1992, 70 (05) :821-828
[4]  
Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x
[5]   CLINICAL HETEROGENEITY IN EPIDERMOLYTIC HYPERKERATOSIS [J].
DIGIOVANNA, JJ ;
BALE, SJ .
ARCHIVES OF DERMATOLOGY, 1994, 130 (08) :1026-1035
[6]  
HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826
[7]   MUTATIONS IN THE ROD 1A DOMAIN OF KERATIN-1 AND KERATIN-10 IN BULLOUS CONGENITAL ICHTHYOSIFORM ERYTHRODERMA (BCIE) [J].
MCLEAN, WHI ;
EADY, RAJ ;
DOPPINGHEPENSTAL, PJC ;
MCMILLAN, JR ;
LEIGH, IM ;
NAVSARIA, HA ;
HIGGINS, C ;
HARPER, JI ;
PAIGE, DG ;
MORLEY, SM ;
LANE, EB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (01) :24-30
[8]   DEFECTS IN THE BARRIER [J].
ROOP, D .
SCIENCE, 1995, 267 (5197) :474-475
[9]   MUTATIONS IN THE ROD DOMAINS OF KERATIN-1 AND KERATIN-10 IN EPIDERMOLYTIC HYPERKERATOSIS [J].
ROTHNAGEL, JA ;
DOMINEY, AM ;
DEMPSEY, LD ;
LONGLEY, MA ;
GREENHALGH, DA ;
GAGNE, TA ;
HUBER, M ;
FRENK, E ;
HOHL, D ;
ROOP, DR .
SCIENCE, 1992, 257 (5073) :1128-1130
[10]  
ROTHNAGEL JA, 1996, CURR OPIN DERMATOL, V3, P127